GHK-Cu + growth hormone secretagogues (MK-677, Ipamorelin, CJC-1295)
Deficiency can lead to megaloblastic anemia
rare reports of transient dizziness or nausea
A patient might misread a concentration (confusing mcg with mg), draw from the wrong vial, or inject a full reconstituted vial instead of a fractional dose
The "gradual decline" group (approximately 40-50% of users) represents modal experience where benefits slowly regress toward pre-treatment baseline over 4-8 months, typically affecting users who completed shorter treatment courses (2-4 months), used lower concentrations or inconsistent application, possessed moderate to severe baseline skin damage requiring ongoing support, maintained adequate but not optimal complementary skincare, experienced significant lifestyle stressors affecting skin health including poor sleep or high stress, and faced genetic or age-related collagen production limitations
The year 1901 was also an important moment for chemists Emil Fischer and Ernest Fourneau, who carried out the first successful peptide synthesis, thus creating the first peptide
